OMRON Healthcare and Tricog Health strengthen collaboration in India with Tricog CardioCheck (TCC)
AI-powered ECG analysis enables rapid risk assessment and supports early detection of heart disease risk Kyoto [Japan], April 23: OMRON Healthcare Co., Ltd., a global leader in clinically proven...
AI-powered ECG analysis enables rapid risk assessment and supports early detection of heart disease risk
Kyoto [Japan], April 23: OMRON Healthcare Co., Ltd., a global leader in clinically proven medical devices for home health monitoring and treatment, today announced the integration of its ECG-enabled upper arm blood pressure monitors with Tricog Health Pte. Ltd.’s clinically validated AI-powered cardiac triage service, Tricog CardioCheck (TCC). The service is scheduled for rollout at health centers across India from April 2026. Tricog CardioCheck (TCC) enables ECG data recorded using OMRON Healthcare’s Complete™ blood pressure monitors with integrated ECG monitoring to be transmitted to the cloud and analyzed by Tricog’s AI algorithms. Within approximately 10 seconds, the system provides a three-level risk assessment, supporting patient triage and timely clinical evaluation Results are displayed via a dedicated smartphone application designed for healthcare professionals, allowing front-line care providers to review patient risk levels in real time and quickly determine the need for further examination, even where a cardiology specialist is not immediately available. Cardiovascular disease represents a growing public health challenge in India, with the number of patients projected to increase from approximately 110 million today to 230 million by 2050. At the same time, access to specialized care remains limited, with far fewer cardiology specialists per capita than in Japan or the United States and limited access to facilities equipped for advanced cardiac testing. While early identification can be crucial to the effective management of cardiovascular conditions such as heart failure and heart attacks, helping to reduce the risk of serious complications, including strokes, many cases go undetected until overt symptoms begin to develop.




